欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DK/H/1784/001
药品名称
Risepallin
活性成分
risedronate sodium salt 5.0 mg
剂型
Film-coated tablet
上市许可持有人
Pharmathen S.A. 6, Dervenakion str. GR - 15351 Pallini Attikis Greece
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Italy (IT)
许可日期
2010/06/03
最近更新日期
2023/09/21
药物ATC编码
M05BA07 risedronic acid
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Multiple (Copy) Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
common_outer_clean all strengths
Date of last change:2024/09/06
Final Product Information
|
common_pil_clean 30mg
Date of last change:2024/09/06
Final PL
|
common_pil_clean 30mg
Date of last change:2024/09/06
Final Product Information
|
common_pil_clean 35mg
Date of last change:2024/09/06
Final PL
|
common_pil_clean 35mg
Date of last change:2024/09/06
Final Product Information
|
common_pil_clean 5mg
Date of last change:2024/09/06
Final PL
|
common_pil_clean 5mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean 30mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean 35mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean 5mg
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase